We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+0.39%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$3.01B
AUM Growth
+$1.08B
Cap. Flow
+$1.16B
Cap. Flow %
38.44%
Top 10 Hldgs %
31.04%
Holding
889
New
375
Increased
214
Reduced
113
Closed
184

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$144M
2
AA icon
Alcoa
AA
+$18.6M
3
NSC icon
Norfolk Southern
NSC
+$17.7M
4
AVGO icon
Broadcom
AVGO
+$15.8M
5
GLNG icon
Golar LNG
GLNG
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 21.64%
2 Healthcare 10.52%
3 Industrials 9.72%
4 Financials 6.92%
5 Consumer Discretionary 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BURL icon
151
Burlington
BURL
$23.2B
$4.65M 0.15%
16,327
+9,541
+141% +$2.58M
JCI icon
152
Johnson Controls International
JCI
$88.8B
$4.65M 0.15%
58,872
+2,378
+4% +$191K
NVT icon
153
nVent Electric
NVT
$24.9B
$4.52M 0.15%
66,259
+31,450
+90% +$2.32M
WBS icon
154
Webster Financial
WBS
$12.5B
$4.46M 0.15%
80,730
+62,333
+339% +$3.42M
GFF icon
155
Griffon
GFF
$3.95B
$4.45M 0.15%
+62,500
New +$4.53M
LITE icon
156
Lumentum
LITE
$55.5B
$4.44M 0.15%
+52,831
New +$4.12M
FERG icon
157
Ferguson
FERG
$45.4B
$4.39M 0.15%
+25,287
New +$5.02M
NXPI icon
158
NXP Semiconductors
NXPI
$57.8B
$4.36M 0.15%
20,989
-7,432
-26% -$1.69M
DYN icon
159
Dyne Therapeutics
DYN
$4.7B
$4.35M 0.14%
184,818
+67,137
+57% +$1.99M
GILD icon
160
Gilead Sciences
GILD
$162B
$4.32M 0.14%
46,779
+5,875
+14% +$529K
MHO icon
161
M/I Homes
MHO
$3.74B
$4.3M 0.14%
+32,344
New +$5.09M
PNC icon
162
PNC Financial Services
PNC
$99.7B
$4.3M 0.14%
22,283
+17,743
+391% +$3.49M
REG icon
163
Regency Centers
REG
$14.7B
$4.29M 0.14%
+57,995
New +$4.24M
DOC icon
164
Healthpeak Properties
DOC
$15.1B
$4.2M 0.14%
+207,118
New +$4.49M
TECK icon
165
Teck Resources
TECK
$29.6B
$4.16M 0.14%
102,685
-161,300
-61% -$7.54M
WSO icon
166
Watsco Inc
WSO
$12.7B
$4.13M 0.14%
8,709
+6,410
+279% +$3.25M
CAH icon
167
Cardinal Health
CAH
$53.9B
$4.12M 0.14%
+34,863
New +$4.07M
SRPT icon
168
Sarepta Therapeutics
SRPT
$1.57B
$4.12M 0.14%
+33,893
New +$4.15M
JLL icon
169
Jones Lang LaSalle
JLL
$16.5B
$4.1M 0.14%
+16,199
New +$4.32M
ADC icon
170
Agree Realty
ADC
$9.34B
$4.07M 0.14%
57,734
+41,310
+252% +$3.08M
MTH icon
171
Meritage Homes
MTH
$4.58B
$4.05M 0.13%
+105,416
New +$9.62M
INTU icon
172
Intuit
INTU
$86.5B
$4.05M 0.13%
6,448
+1,488
+30% +$951K
VRNS icon
173
Varonis Systems
VRNS
$4.59B
$4.03M 0.13%
+90,817
New +$4.72M
BLD
174
DELISTED
TopBuild
BLD
$4.02M 0.13%
+12,907
New +$4.73M
OKTA icon
175
Okta
OKTA
$24.7B
$4.01M 0.13%
50,902
+5,201
+11% +$403K

Similar funds

Crestline Management's Q4 2024 Portfolio in Review

As of Q4 2024, Crestline Management held 889 positions worth $3.01B, up 56% from $1.92B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Crestline Management deployed $1.16B of net new capital in Q4 2024, opening 375 new positions and adding to 214 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 640,000 shares worth $377M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Broadcom, an estimated $15.8M trimmed.

  • Crestline Management's largest Q4 2024 buy was iShares Core S&P 500 ETF: 640,000 shares worth $377M.
  • Crestline Management added most to Invesco QQQ Trust in Q4 2024, an estimated $75.1M increase.
  • Crestline Management's biggest Q4 2024 reduction was Broadcom, cutting an estimated $15.8M.
  • Crestline Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2024, selling an estimated $144M.
  • Crestline Management's ten largest holdings make up 31% of its $3.01B portfolio in Q4 2024.
  • Crestline Management opened 375 new positions and closed 184 in Q4 2024.
  • Crestline Management's portfolio value rose 56% quarter-over-quarter to $3.01B.

Based on Crestline Management's 13F filing for Q4 2024, filed 14 Feb 2025.